Clinical trials
Phase 1/2 Gastrointestinal Stromal Tumors trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Deciphera Pharmaceuticals, LLC | 3 |
| Northwestern University | 2 |
| Asan Medical Center | 1 |
| CStone Pharmaceuticals | 1 |
| Cogent Biosciences, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Esperas Pharma Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| FeRx | 1 |
| Heikki Joensuu | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Stromal Tumors | 20 |
| Sarcoma | 7 |
| Colorectal Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Colonic Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.